Image

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Study on Safety and Effects of Investigational Medicine in Cancer Patients

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates solid tumors and multiple myeloma. The purpose of this study is to assess the safety and effects of an investigational medication in people with these conditions.

The study evaluates the safety, pharmacokinetics, and preliminary activity of the investigational medication. It will look at how the body processes the medication and its initial effectiveness.

  • Who can participate: Adults aged 18 and older with advanced solid tumors or multiple myeloma may participate. Participants must have tried standard therapies without success and meet specific health criteria.
  • Study details: Participants will receive the investigational medication to assess its safety and effects.
Print
Study details
    Ovarian Cancer
    Pancreas Cancer
    Urothelial Carcinoma
    Renal Cell Carcinoma
    Hepatocellular Carcinoma
    Gastrointestinal Cancer
    Lung Cancer
    Prostate Cancer
    Breast Cancer

NCT06582017

Nammi Therapeutics Inc

5 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.